These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8766063)

  • 1. [Giant cell arteritis and normal sedimentation rate: more than an exception!].
    von Blotzeim SG; Borruat FX
    Klin Monbl Augenheilkd; 1996 May; 208(5):397-9. PubMed ID: 8766063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
    Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI.
    Geiger J; Ness T; Uhl M; Lagrèze WA; Vaith P; Langer M; Bley TA
    Rheumatology (Oxford); 2009 May; 48(5):537-41. PubMed ID: 19233887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell temporal arteritis with a normal erythrocyte sedimentation rate: report of a case.
    Ciccarelli M; Jeanmonod D; Jeanmonod R
    Am J Emerg Med; 2009 Feb; 27(2):255.e1-3. PubMed ID: 19371556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of unilateral temporal artery biopsy.
    Hall JK; Volpe NJ; Galetta SL; Liu GT; Syed NA; Balcer LJ
    Ophthalmology; 2003 Mar; 110(3):543-8; discussion 548. PubMed ID: 12623818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis.
    Diaz VA; DeBroff BM; Sinard J
    Ophthalmology; 2005 Jul; 112(7):1293-8. PubMed ID: 15921755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS; Tang RA; Dorotheo EU
    Geriatrics; 2005 Aug; 60(8):26-30. PubMed ID: 16092890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature.
    Zweegman S; Makkink B; Stehouwer CD
    Neth J Med; 1993 Apr; 42(3-4):128-31. PubMed ID: 8316325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis.
    Varma D; O'Neill D
    Eye (Lond); 2004 Apr; 18(4):384-8. PubMed ID: 15069435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis.
    Quinn EM; Kearney DE; Kelly J; Keohane C; Redmond HP
    Ann Vasc Surg; 2012 Jul; 26(5):649-54. PubMed ID: 22285348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients.
    Esteban MJ; Font C; Hernández-Rodríguez J; Valls-Solé J; Sanmartí R; Cardellach F; García-Martínez A; Campo E; Urbano-Márquez A; Grau JM; Cid MC
    Arthritis Rheum; 2001 Jun; 44(6):1387-95. PubMed ID: 11407699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
    Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
    Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.
    Gonzalez-Gay MA; Garcia-Porrua C; Llorca J; Gonzalez-Louzao C; Rodriguez-Ledo P
    Semin Arthritis Rheum; 2001 Feb; 30(4):249-56. PubMed ID: 11182025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Giant-cell arteritis: a descriptive study in southwestern Spain].
    Calvo Romero JM; Magro Ledesma D; Ramos Salado JL; Bureo Dacal JC; de Dios Arrebola García J; Bureo Dacal P; Pérez Miranda M
    An Med Interna; 2000 Feb; 17(2):67-70. PubMed ID: 10829459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
    Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
    Arthritis Rheum; 2004 Aug; 51(4):652-5. PubMed ID: 15334440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-ophthalmic complications of biopsy-proven giant cell arteritis.
    Glutz von Blotzheim S; Borruat FX
    Eur J Ophthalmol; 1997; 7(4):375-82. PubMed ID: 9457462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis.
    Ponge T; Barrier JH; Grolleau JY; Ponge A; Vlasak AM; Cottin S
    J Rheumatol; 1988 Jun; 15(6):997-1000. PubMed ID: 2971112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Giant cell arteritis and polymyalgia rheumatica: diagnosis and evolution of 90 cases].
    Rivero Puente A; Berasategui Calderón JI; Murie Carrillo De Albornoz JM; Rivero Marcotegui M; García-Bragado Acín F
    An Med Interna; 2001 Apr; 18(4):191-4. PubMed ID: 11496538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal to decrease the number of negative temporal artery biopsies.
    Rodríguez-Pla A; Rosselló-Urgell J; Bosch-Gil JA; Huguet-Redecilla P; Vilardell-Tarres M
    Scand J Rheumatol; 2007; 36(2):111-8. PubMed ID: 17476617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.